<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effects and indications of <z:chebi fb="8" ids="29745">barbiturate</z:chebi> therapy for brain protection, and prevention and reduction of the intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> were investigated using an ultrashort acting <z:chebi fb="8" ids="29745">barbiturate</z:chebi>, <z:chebi fb="0" ids="9536">thiamylal</z:chebi>, in sixteen cases with intracranial lesions </plain></SENT>
<SENT sid="1" pm="."><plain>Final outcome of the treatment revealed 8 good recoveries which were actively administered <z:chebi fb="0" ids="9536">thiamylal</z:chebi> during operation or immediately after </plain></SENT>
<SENT sid="2" pm="."><plain>On the other hand, four cases, whose intracranial pressures (ICPS) of over 40 mmHg could not be controlled suffered brain <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="8" ids="29745">Barbiturate</z:chebi> therapy was not effective for brain protection of primary damaged lesions </plain></SENT>
<SENT sid="4" pm="."><plain>It is concluded that <z:chebi fb="8" ids="29745">barbiturate</z:chebi> therapy may provide a satisfactory reduction of the intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> in cases during the early postoperative stage or of under 40 mmHg initial ICP </plain></SENT>
</text></document>